Exclusive

Publication

Byline

Location

US Patent Issued to University of Virginia Patent Foundation on Oct. 27 for "Compositions and related methods for modulating alkaloid production by controlling PMT promoter activation mediated by transcriptional factors ERF and Myc" (American, Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,308, issued on Oct. 27, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.). "Compositions and related methods ... Read More


US Patent Issued to ModernaTX on Oct. 27 for "Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,310, issued on Oct. 27, was assigned to ModernaTX Inc. (Cambridge, Mass.). "Polynucleotides encoding cystic fibrosis transmembrane conducta... Read More


US Patent Issued to University of Virginia Patent Foundation on Oct. 27 for "Compositions and methods for combating multidrug-resistant bacteria" (Virginia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,312, issued on Oct. 27, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.). "Compositions and methods for comb... Read More


US Patent Issued to The Regents of the University of Colorado, a body corporate on Oct. 27 for "Modified follicle-stimulating hormone and methods of using the same" (Colorado Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,313, issued on Oct. 27, was assigned to The Regents of the University of Colorado, a body corporate (Denver). "Modified follicle-stimulatin... Read More


US Patent Issued to The Council of the Queensland Institute of Medical Research (QIMR) on Oct. 27 for "T-cell receptors and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,315, issued on Oct. 27, was assigned to The Council of the Queensland Institute of Medical Research (QIMR) (Hertson, Australia). "T-cell re... Read More


US Patent Issued to The Trustees of the University of Pennsylvania on Oct. 27 for "Anti-CD3 scFv and cytokine producing artificial antigen presenting cells" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,316, issued on Oct. 27, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Anti-CD3 scFv and cytokine producin... Read More


US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Oct. 27 for "Human application of engineered chimeric antigen receptor (CAR) T-cells" (Texas Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,317, issued on Oct. 27, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas). "Human application of engineered ... Read More


US Patent Issued to UTI on Oct. 27 for "Methods of treating liver disease" (Canadian Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,318, issued on Oct. 27, was assigned to UTI LP (Calgary, Canada). "Methods of treating liver disease" was invented by Pedro Santamaria (Cal... Read More


US Patent Issued to BIOVERATIV THERAPEUTICS on Oct. 27 for "Optimized factor VIII genes" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,319, issued on Oct. 27, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.). "Optimized factor VIII genes" was invented by Ajay M... Read More


US Patent Issued to IDEXX Laboratories on Oct. 27 for "Specific detection of clusterin isoforms" (Maine, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,320, issued on Oct. 27, was assigned to IDEXX Laboratories Inc. (Westbrook, Maine). "Specific detection of clusterin isoforms" was invented... Read More